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Fatigue is a frequent disabling symptom in multiple sclerosis (MS),
but its pathophysiology remains incompletely understood. This
study aimed to explore the underlying neural basis of fatigue in
patients with MS.
Methods
We enrolled 60 consecutive patients with MS and 60 healthy
controls (HC) matched on age, sex, and education. Fatigue was
assessed using the Portuguese version of the Modified Fatigue
Impact Scale (MFIS). All participants underwent 3T brain MRI
(conventional and diffusion tensor imaging [DTI] sequences).
White matter (WM) focal lesions were identified and T1/T2 lesion
volumes were computed. Tract-based spatial statistics were applied
for voxel-wise analysis of DTI metrics fractional anisotropy and
mean diffusivity (MD) on normal-appearingWM (NAWM). Using
Freesurfer software, total and regional volumes of cortical and
subcortical gray matter (GM) were calculated.
Results
Compared to HC, patients with MS scored significantly higher on MFIS (33.8 ± 19.7 vs
16.5 ± 15.1, p < 0.001). MFIS scores were not significantly correlated with T1/T2 lesion
volumes, total GM volume, or any regional volume of cortical and subcortical GM. Sig-
nificant correlations were found between global scores of MFIS and MD increase of the
NAWM skeleton, including corona radiata, internal capsule, external capsule, corticospinal
tract, cingulum, corpus callosum, fornix, superior longitudinal fasciculus, superior fronto-
occipital fasciculus, sagittal stratum, posterior thalamic radiation, cerebral peduncle, and
uncinate fasciculus.
Conclusions
In this study, fatigue was associated with widespread NAWM damage but not with lesion load
or GM atrophy. Functional disconnection, caused by diffuse microstructural WM damage,
might be the main neural basis of fatigue in MS.
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Fatigue is reported by more than 80% of patients with
multiple sclerosis (MS) during their disease course and
drastically affects their quality of life.1 Fatigue can be defined
as “a subjective lack of physical and/or mental energy that is
perceived by the individual or caregiver to interfere with
usual and desired activities.”2 Although the clinical aspects of
fatigue are well-recognized, its pathophysiologic mechanisms
remain incompletely understood. Neuroimaging studies
have yielded divergent results regarding a correlation be-
tween fatigue severity and MRI lesion load,3-6 number and
volume of gadolinium-enhancing lesions,7 brain atrophy
measurements,3,8,9 and diffuse damage to the normal-
appearing brain tissues.10,11 Interestingly, several works
have succeeded in establishing a link between fatigue and
cortico-subcortical disconnection.4,12,13 However, most of
these studies only used a single MRI technique and therefore
did not assess the influence of all candidate brain regions and
pathologic mechanisms. The advantage of combining MRI
techniques is to get a more comprehensive view on patho-
physiologic processes underpinning fatigue in MS.
Hence, the aim of this work was to explore the underlying
neural basis of fatigue in patients with MS by means of
a multimodal MRI approach assessing simultaneously the
contribution of cortical gray matter (GM), subcortical GM,
and white matter (WM) pathology.
Methods
Participants
Participants included in this study correspond to the same
dataset previously published by our group.14 It consists of 60
patients with MS regularly followed in our department and
60 healthy volunteers recruited from the community who
served as healthy controls (HC), matched on age, sex, and
education level (table 1).
Patients were eligible if they were ≥18 and ≤55 years of age
with relapsing-remitting or secondary progressive MS
according to the McDonald criteria 2010.15 Participants
were excluded if there was history of an additional neuro-
logic, psychiatric (including clinically relevant depression),
or systemic disorder. Other exclusion criteria included his-
tory of head injury with loss of consciousness; visual, audi-
tory, or language impairment; or drug (including
antipsychotic medication) or alcohol abuse. Participants who
had stopped antidepressants up until 2 months before testing
and patients with MS who had a relapse or used steroids
within 2 months before evaluation were also excluded.
Standard protocol approvals, registrations,
and patient consents
The local ethics committee approved this study and all partic-
ipants gave written informed consent prior to participation.
Clinical assessment
A completemedical history and neurologic examination were
performed in all patients. Expanded Disability Status Scale
Table 1 Demographic and clinical characteristics of patients with multiple sclerosis (MS) and healthy controls (HC)
Patients with MS (n = 60) HC (n = 60) p Value
Age, y, mean ± SD 37.2 ± 7.5 36.1 ± 9.4 0.475
Education, y, mean ± SD 13.2 ± 4.0 14.0 ± 3.9 0.258
Female, n (%) 40 (66.7) 40 (66.7) 1.0
Right handedness, n (%) 56 (93.3) 58 (96.7) 0.539
Disease course, n (%)
Relapsing-remitting 50 (83.3)
Secondary progressive 10 (16.7) NA NA
Disease duration, y, mean ± SD 10.6 ± 6.6 NA NA
EDSS, median (IQR) (min, max) 2.0 (1.5) (1.0, 7.5) NA NA
Total T1 lesion volume, mL, mean ± SD 53.03 ± 44.34 NA NA
Total T2 lesion volume, mL, mean ± SD 16.8 ± 15.8 NA NA
Abbreviations: EDSS = Expanded Disability Status Scale; IQR = interquartile range; Max = maximum; Min = minimum; NA = not applicable.
Although the clinical aspects of
fatigue are well-recognized, its
pathophysiologic mechanisms
remain incompletely understood.
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(EDSS)16 was used to evaluate neurologic disability. For
HC, the medical history was collected through an in-person
interview before assessment. We obtained the following
clinical and demographic data: age, sex, handedness, years of
education, disease duration, and current disease-modifying
treatment.
Fatigue and depression assessment
Fatigue was assessed using the Portuguese version of the
Modified Fatigue Impact Scale (MFIS).17,18 The test con-
tains 21 items and the Portuguese version comprises 2 levels
of fatigue: physical (MFISphy) and cognitive (MFIScog).
The total score (MFIStotal) ranges from 0 to 84, with higher
scores indicating more fatigue. The cutoff score above which
the patient can be considered fatigued is 38. The Beck De-
pression Inventory (BDI)19,20 was used to determine the
influence of depression on fatigue. The BDI comprises a self-
reported response to a multi-choice questionnaire on 21
items, with a score ≥18 indicating clinically relevant
depression.
MRI acquisition and analysis
All participants were examined on a 3T Siemens Magnetom
TrioTim scanner (Erlangen, Germany) using a 12-channel
birdcage head coil. Scans were placed in an axial-oblique
orientation, parallel to the subcallosal line.21 The following
acquisitions were obtained: (1) 2 high-resolution T1-
weighted 3D magnetization prepared rapid acquisition gra-
dient echo sequences; (2) sagittal 3D fluid-attenuated
inversion recovery: repetition time (TR) 5 seconds, echo
time (TE) 388 milliseconds, inversion time 1.8 seconds, field
of view 250 × 250 mm2, yielding 160 slices with 1 × 1 ×
1 mm3 voxel size; (3) diffusion tensor imaging (DTI): TR
7,800 milliseconds, TE 90 milliseconds, number of
excitations 1; matrix, 96 × 96 × 63 contiguous axial slices;
isotropic voxel resolution of 2 × 2 × 2 mm3; bandwidth of
1,628 Hz/pixel and echo spacing of 0.72 milliseconds. The
DTI was acquired along 63 noncollinear directions (b =
1,000 s/mm2), with one scan without diffusion weighting
(b = 0 s/mm2, b0). Of the 120 participants included in the
study, 3 MRI datasets of the MS group were excluded due to
major artefacts that precluded analysis.
A semiautomatic pipeline was used through FreeSurfer
(version 5.3.0, surfer.nmr.mgh.harvard.edu) in a Linux
(CentOS 6) platform22,23 to perform cortical surface re-
construction and volumetric segmentation. The cortical
parcellation was based on the Desikan-Killiany atlas and
volumes were corrected for the estimated total intracranial
volume.14 As we did not find any significant lateral hemi-
spheric differences regarding fatigue in a preliminary analy-
sis, left and right hemispheric volumes were averaged in
order to reduce the number of variables to the smallest
possible set.14 The DTI images were processed using Oxford
University’s FMRIB Software Library (FSL, fmrib.ox.ac.uk/
fsl) version 5.0.9, on a Linux-based platform, following the
tract-based spatial statistics (TBSS) pipeline.14,24 A more
detailed description of the methods used in MRI acquisition
and analysis has been provided elsewhere.14,21
Statistical analysis
Group comparisons were performed using the t test for un-
paired samples, the nonparametric Mann-Whitney U test,
and χ2 test when appropriate. Correlations between MFIS
scores and demographic, clinical, and MRI variables were
examined using Pearson coefficients or Spearman rank order
coefficient when appropriate. These analyses were con-
ducted using SPSS for Windows version 20.0 (SPSS,
Table 2 Demographic and clinical characteristics of fatigued and nonfatigued patients with multiple sclerosis (MS)
Fatigued patients with MS (n = 26) Nonfatigued patients with MS (n = 34) p Value
Age, y, mean ± SD 38.5 ± 7.4 36.2 ± 7.6 0.238
Education, y, mean ± SD 13.1 ± 3.8 13.3 ± 4.2 0.843
Female, n (%) 20 (76.9) 20 (58.8) 0.141
Right handedness, n (%) 24 (92.3) 32 (94.1) 0.488
Disease course, n (%)
Relapsing-remitting 20 (76.9) 30 (88.2) 0.244
Secondary progressive 6 (23.1) 4 (11.8) 0.141
Disease duration, y, mean ± SD 11.1 ± 6.9 10.1 ± 6.5 0.567
EDSS, median (IQR) (min, max) 2.5 (1.5) (1.0; 7.0) 1.75 (1.5) (1.0; 7.5) 0.145
Total T1 lesion volume, mL, mean ± SD 52.53 ± 47.9 53.39 ± 42.4 0.944
Total T2 lesion volume, mL, mean ± SD 18.2 ± 18.9 15.8 ± 13.2 0.566
Abbreviations: EDSS = Expanded Disability Status Scale; IQR = interquartile range; Max = maximum; Min = minimum.
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Chicago). All tests performed were 2-tailed and the statistical
threshold was set at p < 0.05, corrected through the false
discovery rate for multiple testing.
Voxelwise statistics for each skeleton voxel were calculated
using FSL’s randomize tool, which combines permutation
testing and general linear modeling: a 2-sample unpaired t
test for patients with MS vs HCs’ fractional anisotropy (FA)
and mean diffusivity (MD), and a correlation analysis be-
tween MFIS scores and these diffusion metrics for the MS
group, while treating age as a covariate of no interest. WM
voxels with lesions were excluded from the analyses (after
transforming the binary lesion masks to the same standard
space as the FA images) and, therefore, only the normal-
appearing WM (NAWM) was considered for the purpose of
these analyses.
A total of 5,000 permutations were used with threshold-free
cluster enhancement, corrected for multiple comparisons by
controlling for family-wise error (FWE) rates.25 p Values
<0.05 were considered statistically significant.
The skeletal regions with statistical significance were labeled
anatomically bymapping the TBSS FWE-corrected statistical
maps to the JHU-ICBM-DTI-81 WM atlas.26
The mean FA skeleton was also mapped onto the afore-
mentioned atlas, and the total number of voxels per tract was
calculated, which was used to determine the percentage of
voxels with statistical significance within each labeled tract.
The mean p values per labeled region were determined. The
mean and SD of both diffusion metrics were obtained per
participant and for each region.
Data availability
The datasets generated during or analyzed during the cur-




Patients with MS and HC did not differ significantly in ed-
ucational level, age, or sex (table 1). The disease course was
relapsing-remitting in 50 patients with MS (83.3%) and
secondary progressive in 10 patients with MS (16.7%). The
mean disease duration was 10.6 ± 6.6 years and the median
EDSS score was 2.0 (interquartile range 1.5) (min, max 1.0,
7.5). All the patients in our study were receiving disease-
modifying drugs. Analysis between different drug classes was
not within the scope of this study.
Figure 1 White matter tracts
White matter tracts with significant
fractional anisotropy (FA) re-
duction (A) and mean diffusivity
(MD) increase (B) in patients with
multiple sclerosis relative to healthy
controls. Significant regions are dis-
played in red/yellow (gradient of
significance level red < yellow).
Results are shown overlaid on the
meanFA skeleton (A) or on themean
MD skeleton (B), both displayed in
green (nonsignificant regions).White
matter voxels with lesions were ex-
cluded and therefore only the nor-
mal-appearing white matter was
considered for the analysis. p Values
< 0.05 were considered statistically
significant, corrected for multiple
comparisons controlling for family-
wise error rates.
Our results suggest that fatigue is
mainly related to widespread NAWM
damage but not to conventional
lesion load or GM atrophy.
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Fatigue in patients with MS
Fatigue prevalence was 43.3% in patients with MS and
11.7% in HC. The prevalence of fatigue was not signifi-
cantly different between the subgroups of patients with
relapsing-remitting and secondary progressive MS (40% vs
60%, respectively, p = 0.244). Compared to HC, patients
with MS scored significantly higher on physical (MFI-
Sphy), cognitive (MFIScog), and total (MFIStotal)
dimensions of fatigue (19.4 ± 11.5 vs 7.8 ± 8.0, p < 0.001;
14.3 ± 10.1 vs 8.7 ± 7.8, p = 0.001; 33.8 ± 19.7 vs 16.5 ±
15.1, p < 0.001, respectively). In the MS group, scores on
MFISphy, MFIScog, and MFIStotal positively correlated
with scores on BDI (r = 0.546, r = 0.696, r = 0.676, p <
0.001). Only scores on MFISphy and MFIStotal correlated
with EDSS (r = 0.427, p = 0.001; r = 0.296, p = 0.022). Age,
sex, education level, and disease duration were not asso-
ciated with fatigue.
Comparing fatigued and nonfatigued patients with MS, we
found no statistically significant differences in age, sex, edu-
cation, disease course, disease duration, EDSS, or total T1
and T2 lesion volumes (table 2).
MRI correlates of fatigue in MS
Lesion load and GM volumes
MFIS scores (total, physical, and cognitive dimensions) were
not significantly correlated with T1/T2 lesion volumes, total
GM volume, or with any regional volume of cortical or sub-
cortical GM (table e-1, links.lww.com/CPJ/A54).
Tract-based spatial statistics analysis
Compared with HC, patients with MS showed widespread
abnormalities throughout the WM skeleton in both hemi-
spheres defined by significant FA decrease or MD increase
(figure 1).
In patients with MS, the global score of fatigue (MFIStotal)
and physical fatigue (MFISphy) were positively correlated
with MD across widespread WM tracts of both hemispheres,
including anterior and superior corona radiata, internal cap-
sule (retrolenticular, anterior, and posterior limb), external
capsule, corpus callosum (body, genu, and splenium), cere-
bral peduncles, corticospinal tractus, stria of fornix, cerebellar
peduncles (superior, middle, and inferior), medial lemniscus,
pontine crossing tract, superior fronto-occipital fasciculus,
Figure 2 White matter tracts significantly correlated with fatigue in patients with multiple sclerosis
Significant regions correlated with
Modified Fatigue Impact Scale
(MFIS) total (A), physical (B), and
cognitive (C), treating age as
a covariate of no interest, are dis-
played in red/yellow (gradient of
significance level red < yellow).
Results are shown overlaid on the
mean diffusivity skeleton, both
displayed in green (nonsignificant
regions). White matter voxels with
lesions were excluded and there-
fore only the normal-appearing
white matter was considered for
the analysis. Cluster-based thresh-
olding corrected for multiple com-
parisons controlling for family-wise
error rates, with p values < 0.05
considered statistically significant.
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Sign. voxels, %a p Valueb Sign. voxels, %a p Valueb Sign. voxels, %a p Valueb
Anterior corona radiata L 6.96 0.042 0.00 1.000 0.00 1.000
Anterior corona radiata R 10.04 0.043 6.77 0.050 0.00 1.000
Anterior limb internal capsule L 38.71 0.041 12.39 0.047 0.00 1.000
Anterior limb internal capsule R 36.90 0.042 30.26 0.048 0.12 0.040
Body corpus callosum 18.84 0.042 5.50 0.039 0.00 1.000
Cerebral peduncle L 6.00 0.031 4.60 0.030 3.35 0.036
Cerebral peduncle R 18.68 0.038 4.60 0.028 1.87 0.038
Cingulum hippocampus L 4.95 0.038 4.05 0.043 0.00 1.000
Corticospinal tract L 24.87 0.031 23.02 0.029 0.00 1.000
Corticospinal tract R 22.91 0.038 25.07 0.027 0.00 1.000
External capsule L 2.06 0.039 0.50 0.038 0.00 1.000
External capsule R 14.67 0.041 10.17 0.049 0.00 1.000
Fornix stria L 47.95 0.025 49.77 0.024 33.79 0.035
Fornix stria R 66.92 0.028 65.04 0.025 40.23 0.035
Genu corpus callosum 54.54 0.041 15.12 0.049 7.84 0.050
Inferior cerebellar peduncle L 52.63 0.034 57.02 0.030 0.00 1.000
Inferior cerebellar peduncle R 21.56 0.038 28.90 0.037 0.00 1.000
Medial lemniscus L 17.20 0.037 12.74 0.033 0.00 1.000
Medial lemniscus R 24.50 0.037 21.19 0.029 0.00 1.000
Middle cerebellar peduncle 55.94 0.034 53.58 0.028 0.00 1.000
Pontine crossing tract 10.88 0.034 7.72 0.029 0.00 1.000
Posterior corona radiata L 21.20 0.039 13.30 0.042 0.00 1.000
Posterior limb internal capsule L 29.37 0.033 29.37 0.029 5.59 0.034
Posterior limb internal capsule R 18.63 0.038 22.57 0.028 1.97 0.039
Posterior thalamic radiations (OR) L 7.36 0.039 5.94 0.045 0.00 1.000
Posterior thalamic radiations (OR) R 0.00 1.000 0.17 0.047 0.00 1.000
Retrolenticular internal capsule L 25.23 0.033 25.23 0.028 8.94 0.037
Retrolenticular internal capsule R 6.60 0.033 8.72 0.027 0.75 0.036
Sagittal stratum L 2.64 0.036 0.19 0.028 0.00 1.000
Splenium corpus callosum 56.18 0.036 57.62 0.038 0.00 1.000
Superior cerebellar peduncle L 33.03 0.034 26.15 0.029 0.00 1.000
Superior cerebellar peduncle R 35.37 0.034 36.59 0.025 0.41 0.033
Superior corona radiata L 9.96 0.039 6.57 0.044 0.00 1.000
Superior corona radiata R 6.79 0.042 4.40 0.034 0.00 1.000
Superior frontooccipital fasciculus L 63.33 0.040 50.00 0.047 0.00 1.000
Superior frontooccipital fasciculus R 85.00 0.041 77.50 0.048 0.00 1.000
Continued
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left posterior corona radiata, left posterior thalamic radia-
tions, left sagittal stratum, left uncinate fasciculus, left cin-
gulum of hippocampus, and left superior longitudinal
fasciculus (figure 2, A and B).
Cognitive fatigue (MFIScog) was positively correlated with
MD of stria of fornix, genu of corpus callosum, cerebral
peduncles, internal capsule (posterior limb and retro-
lenticular), right superior cerebellar peduncle, and right an-
terior limb of internal capsule (figure 2C). No significant
correlations were found between FA and MFIStotal, MFI-
Sphy, or MFIScog (table 3).
Discussion
In this study, we explored the contribution of GM and WM
damage to fatigue in MS by means of combining two ad-
vanced MRI techniques: DTI with TBSS analysis to assess
WM integrity and FreeSurfer to evaluate cortical and sub-
cortical GM volumes. Our results suggest that fatigue is
mainly related to widespread NAWM damage but not to
conventional lesion load or GM atrophy.
In line with these findings, previous studies demonstrated
that the disruption of neural circuits contributes to generat-
ing fatigue.12 In particular, several associative tracts, such as
frontal and occipital fibers, the uncinate fasciculus, superior
longitudinal fasciculus, external and internal capsules, and
corpus callosum, were electively damaged in patients with
MS. The involvement of fronto-frontal connections and
frontal-connected associative tracts reinforces the role of the
frontal lobes as one of the most important substrates of
fatigue in MS, as previously suggested in other studies.4,11-13
The disruption of the corpus callosum deserves particular
attention, as this structure is a crossroads of pathways linking
not only both frontal lobes but also the presupplementary
motor area and anterior cingulate region with the dorsolat-
eral prefrontal cortex.27 Both executive and working memory
tasks are associated with the activation of the anterior cin-
gulate and dorsolateral prefrontal cortex in both
hemispheres.28,29 Therefore, the association of fatigue with
callosal pathway damage may be related to impaired com-
munication between these structures.4 Callosal damage
proven by structural MRI4 and by MRI spectroscopy30 has
been previously associated with fatigue in MS.
The theory of cortico-subcortical disconnection underlying
fatigue in MS is supported by a growing body of evidence
coming not only from structural but also from functional
MRI studies. Data from 73 patients who had undergone
proton magnetic resonance spectroscopy imaging showed
that the N-acetylaspartate-creatine ratio was significantly
lower in the high-fatigue group, suggesting a widespread
axonal dysfunction.30 Moreover, a functional MRI study has
demonstrated impaired interactions between functionally
related cortical and subcortical areas.31 Bisecco et al.13 con-
ducted a study with a similar approach to the present one
(i.e., DTI with TBSS whole-brain voxelwise analysis) and
also reported an association between fatigue and widespread
microstructural NAWM damage. These authors proposed
that the less extensive increase of axial diffusivity observed in
fatigued patients with MS suggested the presence of a diffuse
axonal loss reflecting the effect of inflammation. However, in
our study, the pattern of DTI measures correlated with MFIS
(increased MD without significant correlation with FA)
suggests that the NAWM damage underlying fatigue is
probably more related to diffuse inflammation/edema than
to irreversible axonal injury. Accordingly, one hypothesis for
the pathophysiology of fatigue in MS is that the in-
flammatory milieu in the CNS might produce symptoms of
fatigue by inducing functional alterations in the brain
networks.32
Studies are inconsistent regarding the association between
fatigue and total measures of lesion load and atrophy in MS.
Two studies reported an association between fatigue and
higher T1 and T2 lesion load3,4 and in one of these studies
the authors also found an association between lower white
matter and gray matter fraction and fatigue inMS.3 However,
several other studies did not find any association between
these fractions and fatigue, which is in line with our
results.6,9,11,13,32 Possible explanations for these discrep-
ancies include differences in patients’ clinical characteristics




Sign. voxels, %a p Valueb Sign. voxels, %a p Valueb Sign. voxels, %a p Valueb
Superior longitudinal fasciculus L 0.70 0.039 0.70 0.045 0.00 1.000
Uncinate fasciculus L 23.81 0.035 0.00 1.000 0.00 1.000
Abbreviations:MFIScog =Modified Fatigue Impact Scale cognitive score;MFISphy =Modified Fatigue Impact Scale physical score;MFIStotal =Modified Fatigue
Impact Scale total score.
Fractional anisotropy values are not displayed in the table as no significant correlations were found with MFIStotal, MFISphy, or MFIScog.
a Percentage of significant voxels within each labeled tract.
b p Values < 0.05 were considered statistically significant (corrected for multiple comparisons by controlling for family-wise error rates).
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(disease duration, concomitant presence of depression and
cognitive impairment); use of different fatigue scales and
sample sizes; sensitivity of the technique applied to different
substrates of MS pathology; and methods used for the
analysis (e.g., global vs regional assessment).11
Regarding the contribution of GM pathology to fatigue in MS,
previous studies have suggested that the main contributor is
multiregional damage rather than global brain damage.9,11,33
The regional analysis supported the role of specific brain
regions in the pathogenesis of this symptom, particularly the
thalamus,9,33 basal ganglia nuclei,33,34 and frontal,4,11,34 tem-
poral,11 and posterior parietal8,34 cortices. On the contrary, in
the current study, fatigue was not correlated with any regional
volume of cortical and subcortical GM.
There are some limitations to this study to be considered.
First, its cross-sectional design may interfere with group
comparison and therefore limit the generalization of our
findings. Nevertheless, the overlap with previous studies
supports the validity of our results. Second, the patients had
relatively mild disability (median EDSS score 2.0) and most
of them had a relapsing-remitting subtype of MS. There-
fore, we could not define if the results of the current study
are fully applicable to all patients with MS. Third, the re-
lationship between fatigue and treatment with different
disease-modifying drugs was not explored. In addition,
we did not assess whether the patients were on therapies
for fatigue, which might have altered their fatigue scores.
Finally, a functional MRI examination was not included
in the present study. As a consequence, we could not ana-
lyze the functional correlates of the widespread NAWM
damage.
Fatigue in its physical and cognitive dimensions was associ-
ated with diffuse lesion of NAWM but not with GM atrophy
or conventional lesion load. This strengthens the hypothesis
that the main neural basis of fatigue in MS might be a func-
tional disconnection caused by diffuse microstructural dam-
age of NAWM.
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